Arguing that the body has learned a lot "from the lessons our experience with generic drugs has taught us," they are going to accelerate biosimilar competition based on four key strategies.
recently published
Horizon scanning
Jan 31 2024
Early Treatment: the role of biosimilars
18 2023 December
